Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Gang Cui & Youchao Xiao. (2022) Identification of SAA1 as a prognostic biomarker associated with immune infiltration in glioblastoma. Autoimmunity 55:6, pages 418-427.
Read now
Read now
Articles from other publishers (5)
Zhuo Zhang, Duoli Zhang, Fang Wang, Jiao Liu, Yuhong Sun, Songyot Anuchapreeda, Singkome Tima, Zhangang Xiao & Suwit Duangmano. (2023) Sema4D silencing increases the sensitivity of nivolumab to B16-F10 resistant melanoma via inhibiting the PI3K/AKT signaling pathway. PeerJ 11, pages e15172.
Crossref
Crossref
Cecilia Bica, Alexandru Tirpe, Andreea Nutu, Cristina Ciocan, Sergiu Chira, Eugen S. Gurzau, Cornelia Braicu & Ioana Berindan-Neagoe. (2023) Emerging roles and mechanisms of semaphorins activity in cancer. Life Sciences 318, pages 121499.
Crossref
Crossref
Zexu Lin, Xin Lin, Yuming Sun, Shaorong Lei, Gengming Cai & Zhexuan Li. (2023) Melanoma molecular subtyping and scoring model construction based on ligand-receptor pairs. Frontiers in Genetics 14.
Crossref
Crossref
Satoshi Nojima. (2022) Class IV semaphorins in disease pathogenesis. Pathology International 72:10, pages 471-487.
Crossref
Crossref
Ni Zeng, Qingyue Xia, Yueyue Li, Liwen Ma, Yuxin Cheng, Yihe Chen, Qian Lu, Zhiyu Lu, Di Wu & Dan Luo. (2022) Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting
Survival for Cutaneous Melanoma. Current Pharmaceutical Design 28:28, pages 2349-2361.
Crossref
Crossref